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Abstract
The unique properties of embryonic stem cells (ESC) rely on long-lasting self-renewal and their ability to switch in all adult
cell type programs. Recent advances have shown that regulations at the chromatin level sustain both ESC properties along
with transcription factors. We have focused our interest on the epigenetic modulator HP1c (Heterochromatin Protein 1,
isoform c) that binds histones H3 methylated at lysine 9 (meH3K9) and is highly plastic in its distribution and association
with the transcriptional regulation of specific genes during cell fate transitions. These characteristics of HP1c make it a good
candidate to sustain the ESC flexibility required for rapid program changes during differentiation. Using RNA interference,
we describe the functional role of HP1c in mouse ESC. The analysis of HP1c deprived cells in proliferative and in various
differentiating conditions was performed combining functional assays with molecular approaches (RT-qPCR, microarray). We
show that HP1c deprivation slows down the cell cycle of ESC and decreases their resistance to differentiating conditions,
rendering the cells poised to differentiate. In addition, HP1c depletion hampers the differentiation to the endoderm as
compared with the differentiation to the neurectoderm or the mesoderm. Altogether, our results reveal the role of HP1c in
ESC self-renewal and in the balance between the pluripotent and the differentiation programs.
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Introduction
Embryonic stem cells (ESC) are the pluripotent cells that give
rise to the differentiated cells of the three germ layers at the earliest
stages of development (endoderm, mesoderm and ectoderm) [1].
In mice, these cells are derived from the inner cell mass of
blastocysts and are capable of prolonged self-renewal in vitro. ESC
maintenance is supported by a conserved and restricted set of key
transcription factors, namely Oct4 [2,3], Nanog [4,5] and Sox2
[6,7].
Characterization of these cells has shown that the progression
from a pluripotent to differentiated status is correlated with
chromatin condensation [8] and enrichment in silenced chromatin
marks (see [9] for review) through heterochromatin formation. In
contrast, the chromatin in ESC is relaxed with loosely attached
architectural proteins [10] and a globally permissive transcrip-
tional state [11] characteristic of euchromatin. Recently, RNA
interference screens targeting chromatin-associated proteins have
revealed the existence of ESC regulations at the chromatin level
that contribute to their open chromatin state and that are
important for ESC properties, namely their self-renewal and their
pluripotency [12,13].
It has also been shown that epigenetic modifiers involved in the
methylation status of H3K9 contribute to ESC maintenance under
the control of the transcription factor Oct4 [14,15]. This mark is
involved in heterochromatin formation and in the permanent
silencing of specific genes in transcriptionally active euchromatic
regions when appropriate [16,17]. Notably the ESC-specific
H3K9 methyltransferase ESET is involved in pluripotency
maintenance through the repression of differentiation genes [15].
The inducible H3K9 methylation also contributes to the
epigenetic flexibility associated with the commitment to differen-
tiation, as revealed by the requirement for the euchromatin-
associated G9a H3K9 methyltransferase during early embryonic
development [18] as well as in the silencing of euchromatic loci
during ESC differentiation [19]. Methylated H3K9 marks are
poorly represented in ESC when compared with marks associated
with active genes [20,21] and it is not known whether epigenetic
regulators recognizing methylated H3K9 sustain ESC identity
with similar or distinct functions when compared with other
regulators on activation marks [12,13].
Methylated H3K9 marks are recognized by epigenetic regula-
tors in the heterochromatin proteins 1 (HP1) family, which is
conserved in a large number of species [22]. Mammals have three
HP1 variants: a, b and c. These proteins are capable of homo- or
heterodimerizing and recruiting large protein complexes that are
involved in gene regulation (see [23] for review). Despite their
structural resemblance to one another, the three isoforms have
some distinct, non-redundant functions [24] and localization
patterns. HP1c, and to a lesser extent HP1b, localizes not only to
heterochromatic sites, as does HP1a [25] but also to euchromatic
region [26] to repress gene transcription. Localization of HP1
proteins is submitted to important changes during differentiation
[27–28] which probably accounts for the chromatin organization
during ESC differentiation. However, HP1c is also associated with
the transcriptional activation of direct target genes [29–32]. This
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sustain gene expression in ESC. This characteristic reconciliates
repressive chromatin marks with transcriptional activity and may
provide flexibility for the rapid reprogramming that occurs during
ESC differentiation.
To test this hypothesis, we have explored the functional
consequences of HP1c deprivation on mouse ESC maintenance
and differentiation. We show in this study that HP1c regulates
ESC identity being involved in ESC self-renewal and in the
balance between pluripotency and differentiation.
Results
Embryonic stem cells with low levels of HP1c show
reduced self-renewal efficiency
The role of HP1c in ESC was examined by RNA interference
via lentiviral vectors encoding a short hairpin RNA (shRNA). Four
shRNA constructs designed against HP1c were tested in
comparison to a control construct (shCTR) with at least 4 base
pair mismatches to any known mouse gene. Among the four
shRNA constructs tested, two (shN1 and shN2) specifically
decreased the level of HP1c mRNA by more than 80% and were
used in subsequent experiments. Western blot analysis showed that
after 6 days of puromycin selection to maintain the shRNA
construct, the level of HP1c protein was dramatically decreased in
HP1c shN1 and shN2 cell lines compared to shCTR cells
(Figure 1A). The N1 and N2 shRNA did not induce any decrease
in the levels of HP1a and HP1b mRNAs, demonstrating their
specificity toward HP1c (Figure 1B).
In the presence of puromycin, shHP1c ESC could be
maintained in culture and showed no evidence of morphological
change (not shown). However, both lines grew more slowly than
did control ES cells. To quantify this proliferative defect, cells were
plated at low density and counted daily. The growth curves
obtained (Figure 1C) demonstrated that the cell growth was
reproducibly reduced in both shHP1c cell lines compared to
control ESC. This observation was confirmed by a proliferation
assay that measured BrdU (BromodeoxyUridine) incorporation in
newly synthesized DNA during a unique cell cycle and which
showed around 20% decrease in DNA synthesis in the shHP1c cell
lines compared to the shCTR line (Figure 1D).
To explore the underlying cause of this proliferation defect, we
investigated cell death by measuring the incorporation of the
nucleic acid intercalating agent propidium iodide (PI) which is
actively excluded from viable cells and retained in membrane-
permeant dead cells. To detect early cell death events, annexin V
labeling was used to detect the translocation of this phosphatidyl-
serine protein from the inner to the outer leaflet of the plasma
membrane occurring only in apoptosing cells [33]. The mean
percentage of total dead cells was quite similar in shHP1c cells and
in shCTR cells (CTR : 662%, N1: 762%, N2=762%,
measured from three independent experiments), and therefore
could not explain the cell number decrease specifically observed
upon HP1c knockdown. Another explanation for the lower growth
of cell population could be cell cycle arrest. We performed cell
cycle analyses using propidium iodide and BrdU to label
proliferating cells (Figure 1E). The cell cycle distribution of the
cells was not affected by HP1c repression.
Altogether, these results demonstrate that the down regulation
of HP1c in mESC leads to a decrease in cell growth that is not the
consequence of blockage in the cell cycle or of an increase in cell
death. It thus appears that the cell growth decrease observed in
HP1c depleted cells is due to an overall slowing down of the cell
cycle. To better understand the mechanisms of the proliferation
defect in shHP1c cells, a microarray analysis of their transcripts
was undertaken and compared with those in control cells. As
shown in Table 1, 34 genes were differentially regulated between
the two cell lines with a fold change higher than 2.2. Very
strikingly, 6 of the 18 genes with a known function are associated
with the positive regulation of cell growth. All of these 6 genes
were down regulated (variations confirmed by RT-qPCR, Table
S1), while one gene associated with the repression of cell
proliferation was induced. Hence, these results show that HP1c
is involved in the regulation of ESC self-renewal most probably
through the direct or indirect control of cell growth-associated
genes.
The knock-down of HP1c increases the propensity of ESC
to differentiate
Because the slowing down of proliferation and the commitment
to differentiation are known to be correlated in ESC, we wondered
whether this balance was disrupted in HP1c knockdown cells.
Accordingly we explored the expression level of differentiation
associated genes by RT-qPCR. The results from three indepen-
dent RT-qPCR experiments indicate that shHP1c cells sporadi-
cally expressed differentiation markers in proliferative conditions
(Figure 2A). The two shHP1c cell lines did not always exhibit the
same levels of a given transcript and distinct degrees of variation
were observed between the experiments in all cell lines. However,
when considering all the markers of a specific germ layer, a
reproducible tendency toward the induction of neuroectoderm
differentiation markers (Fgf5, Nestin, and Sox1) was observed in
shHP1c cells. The inductions of some mesoderm markers were
detected but with very low intensity and with a strong variability.
On the contrary the basal level endoderm markers (Foxa2, Gata4,
Gata6) seemed rather lowered. These results suggest that shHP1c
cells are poised to differentiate, though they have not yet
specifically done so. Indeed, the expression of the pluripotency
genes was maintained. As shown in Figure 2B, the mRNA
expression levels of Oct4, Nanog and Sox2 were similar in both
shHP1c cells and control cells, indicating that the decrease in
HP1c expression did not affect the genes controlling ESC
maintenance or pluripotency at the population level. The
microarray analysis confirmed that the decrease in HP1c protein
does not affect the expression level of 13 other genes reported to be
associated with pluripotency [34] (Figure 2C). Moreover, we
quantified the presence of the pluripotent stem cell antigen SSEA1
(Stage-Specific Embryonic Antigen-1) by flow cytometry. The
proportion of SSEA1-positive cells was similar (around 80% of the
whole population) in control and in shHP1c cells (Figure 2D).
Altogether this data indicate that the same proportions of cells
harboring pluripotency markers could be found in CTR, N1 and
N2 populations.
The increased expression of differentiation markers in HP1c
knockdown cells could reflect an increased background of gene
expression in all cells, or alternatively an increase in the number of
cells expressing basal levels of these markers. To distinguish
between these two hypotheses ES cells were stably transfected with
a construct where GFP expression was placed under the control of
the promoter of the mesodermal marker brachyury [35].
Engineered ES cells were subsequently transfected with shRNA
CTR, N1 or N2. The knock-down of HP1c strongly increased the
percent of brachyury GFP cells (Figure 3A) but the mean
fluorescence intensity was not affected (Figure 3B). These
observations confirm that mesoderm markers were also induced
despite the low and sporadic increase of brachyury transcripts
(Figure 2A) in the whole ES cells population. Altogether qPCR
analysis and the reporter assay indicate that lowering the level of
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differentiate toward the neurectoderm and the mesoderm.
The maintenance of mouse ESC is sustained by the LIF
cytokine in the culture medium [36]. To quantify this increased
propensity to differentiate we performed a colony-forming assay
with decreasing LIF concentrations (Figure 4). After 5 days of
culture, the differentiation status of colonies was analyzed by
alkaline phosphatase (AP) staining, which specifically marks
pluripotent cells. The colonies were scored as undifferentiated,
mixed or differentiated. The answers to LIF privation were dose-
dependent but more pronounced in shHP1c cell lines. Specifically,
we noticed that seeding the cells in culture medium supplemented
with only 10 U.mL
21 of LIF induced the formation of a
significantly increased number of mixed colonies by shRNA-
treated ESC compared to control cells. Indeed, in this condition
the vast majority of colonies formed by N1 and N2 cells were
mixed or differentiated (respectively 83% and 81%), as compared
to less than 40% for CTR colonies. The same effect was also seen
in the presence of 1 U.mL
21 with no undifferentiated and more
differentiated colonies that were scored in N1 and N2 than in
CTR cells.
Taken together these results show that low levels of HP1c
increase the propensity of ESC to differentiate but do not induce
their spontaneous progression toward differentiation. They rather
induce ESC to enter a metastable state more sensitive to
differentiating conditions.
Low levels of HP1c increase ESC differentiation efficiency
but restrict the differentiation pattern
The above data suggest that HP1c may be involved in the very
early steps of differentiation, during the commitment process. An
early time point of differentiation was therefore analyzed for gene
expression in embryoid bodies (EB) formed over a 36 h period by
shCTR and shN2 cells. At this time point, Oct4 and Sox2 were
Figure 1. HP1c knockdown ESC exhibit an altered proliferation rate. A. Two different shRNA directed against HP1c (shN1 and shN2) were
compared to a control shRNA (shCTR). Knockdown efficiency was measured by western blot using an anti-HP1c antibody and compared to the basal
level expressed in untransduced ESC and in shCTR cells. Beta-tubulin was used as a protein loading control. B. mRNA levels of the three HP1 isoforms
HP1a, b and c were measured by RT-qPCR. Values are represented relative to the ones obtained from shCTR-transduced cells. C. Growth curves for
the shCTR, shN1 and shN2 cell lines representing the number of cells obtained after 1, 2, 3 or 4 days of culture. D. Proliferation measured by BrdU
incorporation. BrdU was added to exponentially proliferating cells during the last 8 hours of culture. Results are represented relative to the value
obtained in the shCTR cell line. Results are the means of three independent experiments. ** p,0,002 by t test. E. Cell cycle analysis using propidium
iodide (PI) and BrdU incorporation. All values are means +/2 SD from three independent experiments.
doi:10.1371/journal.pone.0015507.g001
Role of HP1c in Embryonic Stem Cells
PLoS ONE | www.plosone.org 3 November 2010 | Volume 5 | Issue 11 | e15507still expressed but the other core pluripotency transcription factor,
Nanog, was already repressed (Figure 5A). Associated with the
repression of Rex1, this indicates that the cells were committed to
differentiation but that the differentiation was not fully achieved.
Differentiation markers (list generated by an automatic analysis of
the bibliography and displayed as supplementary material File S1)
were selected for analysis and clustered based on gene expression
(Figure 5B).
During differentiation the genes were either down- or
upregulated (Figure 5B, groups I and II, respectively). The genes
whose expression changed during differentiation globally displayed
the same regulation in control cells and in HP1c knockdown cells
but with a notably higher amplitude (Figure 5B, clusters a and c).
A restricted number of genes showed either impaired variation
when compared with control cells (clusters b and d) or variation
restricted to cells with low levels of HP1c (Figure 5B, cluster e), but
Table 1. Genes misregulated following HP1c knock-down in proliferating ESC.
Gene symbole Gene Name
a
Fold
change Fonction
b
Mep1b Meprin 1 beta 5.3 Tissue repair ; Cell migration; Modulation of the immune system
Frmd4b FERM domain containing 4B 5.2 Unknown
Aass Aminoadipate-semialdehyde synthase 4.4 Lysine degradation pathway
Hspb7 Heat shock protein family, member 7 4.2 Unknown
AI662270 Expressed sequence AI662270 3.9 Unknown
Fv1 Friend virus susceptibility 1 3.6 Inhibition retroviral infection
Mthfd2l Methylenetetrahydrofolate dehydrogenase
2- like
3.5 Unknown
Clca4 Chloride channel calcium activated 4 3.3 Chloride transport
* Ifitm3 Interferon induced transmembrane protein 3 3.1 Repression of cell proliferation; Cell adhesion
2310043M15Rik RIKEN cDNA 2310043M15 gene 3.0 Unknown
Il1rl2 Interleukin 1 receptor-like 2 2.6 Unknown
Ap1s3 Adaptor-related protein complex AP-1,
sigma 3
2.6 Cargo protein
Gtsf1 Gametocyte specific factor 1 2.5 Unknown
1200003I07Rik RIKEN cDNA 1200003I07 gene 2.4 Unknown
D4Wsu114e Migration and invasion inhibitory protein 2.2 Inhibition of cell invasion and migration
Hydin Hydrocephalus inducing 211.2 Cilia Motility
Msln Mesothelin 25.6 Unknown; Associated with ovarian cancers and mesotheliomas
Cbx3 Chromobox homolog 3 ( HP1g) 24.9 Cbx3
Taok3 TAO kinase 3 24.0 Unknown
* Aldh3a1 Aldehyde dehydrogenase family 3,
subfamily A1
24.0 Activation of cell growth
* Gpx2 Glutathione peroxidase 2 23.8 Activation of cell growth of cancer cells; Inhibition of migration and
invasion; Regulation of hyperoxides level
* Pla2g1b Phospholipase A2, group IB 23.6 Activation of cell growth ; Cell migration; digestion of
glycerophospholipids
Cabp4 Calcium binding protein 4 23.5 Important for normal synaptic function
LOC331480 Predicted gene, EG331480 23.4 Unknown
Tmem40 Transmembrane protein 40 23.4 Unknown
Tmprss5 Transmembrane protease serine 5 (spinesin) 23.2 Unknown
Acoxl Acyl-Coenzyme A oxidase-like 23.1 Unknown
Myom2 Myomesin 2 23.0 Interconection of the major structure of sarcomeres
Crxos1 Crx opposite strand transcript 1 23.0 Unknown
* Ckmt1 Creatine kinase mitochondrial 1 23.0 Activation of cell growth ; Cell viability; Cellular energy homostasis
Fxyd4 FXYD domain-containing ion transport
regulator 4
22.9 Unknown
Ggt1 Gamma-glutamyltransferase 22.9 Glutathione metabolism ; Regulation of osteoclast biology
*Calml4 Calmodulin-like 4 22.8 Activation of cell growth
*Nrp2 Neuropilin 2 22.2 Activation of cell growth; Angiogenesis; Migration of cancer cells;
Functions in nervous system
aGenes with a fold change higher than 2.2 in three independent chip hybridization experiments;
bFunctions given based on bibliography analysis.
*Genes affecting cell proliferation.
doi:10.1371/journal.pone.0015507.t001
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thus indicate that the decrease of HP1c level probably favors the
differentiation of embryonic stem cells from the earliest steps by
increasing the expression of differentiation markers.
To determine whether HP1c knockdown also affected the later
phases of differentiation a kinetic study of gene expression in
embryoid bodies cultivated for 1 to 7 days was done by RT-QPCR
(Figure 6). The down-regulation of the pluripotency genes Oct4
and Nanog was observed in controls and in HP1c knockdown cells
(N1 and N2 cells). When considering markers of differentiation the
situation was very different depending on the germ layers
considered. The peaks and levels of expression of the neuroecto-
dermal genes Sox1, Nestin, Musashi, were similar in the three
populations. The same was true for the mesodermal markers
Brachyury, Eomes And Mixl1. The situation was completely
different for the endodermal markers Gata4, Gata6, Cxcr4, Pdgfra
presenting a tendency to lower expression levels at the time as the
maximum was reached in control cells. These results thus indicate
that the low level of HP1c impairs the differentiation of embryoid
bodies toward the endoderm. To further explore the role of HP1c
in the orientation of ESC differentiation we then used retinoic acid
to induce a rapid differentiation, preferentially toward neuroec-
toderm and to a lesser extent to endoderm (Figure 7). The analysis
by RT-qPCR showed that the expression of the pluripotency
markers Oct4 and Nanog decreased rapidly and similarly in
shHP1c and control cells at day 2. The expression of the
neuroectoderm-associated genes (Fgf5, Sox1 And Nestin) and of
Figure 2. HP1c knocked-down ESC sporadically express differentiation markers but show normal expression of pluripotency
markers. A. The expression of the indicated genes representing the three germ layers (neuroectoderm, mesoderm and endoderm) was measured by
RT-qPCR. Results from three independent RNA samples are reported to illustrate the variability of the results obtained when genes are analyzed
individually. B. The RNA expression levels of the core set of transcription factors required to sustain pluripotency was measured in shRNA cell lines by
real time PCR. C. Fold change of additional markers associated with pluripotency obtained from microarrays analysis. Results are mean +/2 SD of
three independent microarrays experiments. D. The proportion of undifferentiated cells in the three shRNA cell lines was measured by
immunolabelling of SSEA1 and subsequent flow cytometry analysis. In A, B and C results are reported as a ratio of the values obtained in the shCTR
cells. For B and D, the means and standard errors were calculated from four independent experiments.
doi:10.1371/journal.pone.0015507.g002
Figure 3. HP1c knockdown increases the proportion of cells
expressing the differentiation marker Brachyury. ESC transfected
with a Brachyury promoter-GFP construct were further transfected with
the three shRNA. The promoter activity was followed by GFP expression
measured by flow cytometry. A. The proportion of GFP positive cells is
reported as the ratio of the value obtained in the shCTR cells. B.
Representation of the mean fluorescence intensities (MFI) in GFP
positive cells. The means and standard errors were calculated from four
independent experiments. *** p,0.02 by t test.
doi:10.1371/journal.pone.0015507.g003
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kinetics in controls and HP1c knockdown cells but their expression
was enhanced in repressed cells. Both sets of sh RNA against
HP1c gave the same results in spite of uneven efficiency. In
contrast, the expression of the endodermal markers Gata4, Gata6,
Foxa2 and Hnf1 was not increased, showing similar or lower levels
in sh HP1c cells.
Altogether these results show that knockdown of HP1c cells
enhances the early commitment and drives differentiation in a way
that limits the expression of endodermal markers in comparison
with other lineages in both embryonic and retinoic acid
differentiated cells.
HP1c is not regulated at the protein level during
differentiation
Since the expression level of HP1c affects the ability of ESCs to
differentiate, we wondered whether HP1c might be regulated in a
differentiation-dependent manner. The differentiation of ESCs
was followed by a decrease in Oct4 protein levels when induced by
retinoic acid, or by a decrease in Nanog protein levels when
induced by embryoid bodies formation, as observed by western
blot analysis. Within the same time periods, no change in the level
of HP1c protein was observed (Figure 8), indicating that the
activity of HP1c in ESCs was not controlled at this level.
Discussion
Numerous reports have described the major epigenetic
modifications associated with the differentiation of ESC, but very
little is known about the epigenetic regulators that interpret these
chromatin marks and control the switch from the pluripotent state
to the differentiation programs. We have focused our interest on
the chromatin associated protein HP1c protein that, in addition to
its role in the recruitment of transcriptional regulators, is
associated with both the negative [37] and positive [29,30,32]
regulation of gene transcription in the euchromatic regions [31]
undergoing profound change during differentiation [8,9].
Using an RNA interference approach to study the role of HP1c
in ESC, the results presented here show that HP1c is involved in
the self-renewal of ESC, in their commitment to differentiation
and in the orientation of differentiation.
In proliferating conditions ESC repressed for HP1c have a
reduced proliferation rate. However they can be expanded,
cultivated during this study with no limitation of time and do
not show obvious morphological change. We rejected any cell
cycle arrest or accumulation of dead cells as possible causes of the
decreased proliferation rate. It has been reported that the
knockdown of both HP1a and HP1c by RNAi in HeLa cells
abolishes the localization of the HP1-interacting kinetochore
protein hMis12, resulting in aberrant chromosome segregation
[38]. However, the authors have pointed out some functional
redundancy between the two HP1 isoforms. In ESC, the presence
of HP1a certainly prevented the cells from undergoing massive
death due to mitotic catastrophe. We also failed to detect any
increase of the b-galactosidase activity characteristic of senescent
cells and expected if the protection of ESC from ageing was
disrupted [39,40] (data not shown). Therefore the self-renewal
decrease of cells knocked-down for HP1c results probably from a
slowing-down of the cell cycle as a consequence of the
deregulation of direct or indirect HP1c target genes. Indeed,
some cell growth regulators were misregulated upon HP1c knock
down. Hence, the function of HP1c in ESC appears to be the
control of self-renewal shown to result from the inhibition of
differentiation inducing signaling [41]. It is noteworthy that this
impact of HP1c on proliferation seems to be restricted to highly
self-renewing cells. Indeed, it has been shown that siRNA against
HP1c decreases the proliferation of cancer cell lines but not of
noncancer-derived cell lines [42].
In ESC, as a probable consequence of the self-renewal defect,
HP1c depletion was found to disturb the balance between self-
renewal and differentiation. First, the sporadic expression of
differentiation genes that is inherent to ESC populations [11] was
increased in HP1c knocked-down cells, in correlation with an
increased proportion of cells activating the promoter of the
differentiation gene Brachyury. Second, an increased propensity to
Figure 4. A low level of HP1c favors ESC commitment to differentiation. The three shRNA cell lines (shN1, shN2 and shCTR) were seeded at
low density and cultured with medium containing the indicated concentrations of LIF; the concentration of 1000 U/ml corresponds to that used
in proliferating medium. Five days after seeding, colonies were fixed, stained for alkaline phosphatase and scored as undifferentiated (AP+), mixed
(AP+/2) or differentiated (AP-). For each concentration of LIF, results are represented as the percent of the total number of colonies. Means and
standard errors were calculated from three independent experiments, and t tests were performed to determine the significance of the differences
between shHP1 and shCTR cells at each LIF concentration for a given type of colony (AP+, AP- or mixed). * p,0.1, ** p,0.05, *** p,0.02.
doi:10.1371/journal.pone.0015507.g004
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controls ESC maintenance was removed. However, in proliferat-
ing conditions the expression of several pluripotency markers,
among which Oct4, Sox2, Nanog, Rex1 and SSEA1, was not
affected, indicating that HP1c depletion did not induce the
spontaneous differentiation of ESC. The concomitant expression
of pluripotency and differentiation makers along with proliferation
defects show some similarities with the phenotype recently
described for another chromatin associated protein, the histones
acetyl transferase Tip60-p400 [13] that associates with Nanog.
Similarly shHP1c cells share some common features with the
reported phenotype of Nanog knockout ESC, which also remain
self-renewing but have a reduced proliferation rate and an
increased sensitivity to LIF privation [4,5,43]. This observation
suggests that like Nanog, HP1c may serve to block the transition
toward differentiation. Whether the low proliferation rate of HP1c
knocked-down ESC is the cause or the consequence of the
sporadic expression of differentiation genes is not elucidated here.
It cannot be excluded that HP1c contributes to the repression of
these differentiation genes. It is however intriguing that among the
restricted number of genes reproducibly misregulated by HP1c
knock down in ESC (less than 0.1%), a strong proportion is
associated with the control of cell proliferation and not with
differentiation, suggesting that the increased and sporadic
expression of differentiation markers in ESC is the indirect
consequence of the proliferation defect. It is of note that self-
renewal is controlled by the classical Oct4/Sox2/Nanog set of
transcription factors involved in differentiation blockage but also
by another group of genes that directly regulate targets involved in
cell cycle and cell survival [44]. This situation indicates that the
ESC proliferation rate probably results from the cumulative effect
of direct and indirect regulation pathways. The analysis of the
transcripts in early-differentiating ESC indicated that the depletion
of HP1c mostly amplifies the variations of genes expression that
are also targeted in control cells. In contrast, the genes specifically
misregulated by HP1c knock down during differentiation
represent a minority. This expression pattern reinforces the idea
that the function of HP1c is to block the commitment of ESC
toward differentiation.
Another important consequence of HP1c depletion in ESC is to
disadvantage differentiation toward the endoderm when com-
pared with the neuroectoderm and/or the mesoderm pathways
that in contrast were amplified. Further illustrating this bias, we
observed that in proliferating conditions, markers of the three
germ layers were detectable but only those of the neuroectoderm
and the mesoderm were sporadically increased in cells with low
level of HP1c. These results indicate that in addition to its role in
the balance between self-renewal and differentiation, HP1c is
required to manage the endoderm differentiation.
HP1 proteins are known to interact with numerous proteins,
being described as a docking platform for some transcription
factors [45]. In ESC HP1c is abundantly expressed and its
expression remains constant following differentiation induction,
supporting the existence of non-transcriptional mechanisms to
specify the different functions of HP1c in ESC and upon
differentiation such as post-translational modifications or the
interaction with distinct binding proteins. In embryonic carcinoma
cells the interaction between the transcription factor TIF1b and
HP1 proteins sustains endoderm differentiation and is essential for
late endoderm formation [46]. It can thus be assumed that the
interaction between HP1c and TIF1b accounts for the phenotype
described here on the orientation of differentiation.
To conclude, our results support the growing evidence that a
group of epigenetic regulators including HP1c, Tip60/p400 [13]
and Chd1 [12], are involved in the regulation of ESC properties
by acting on ESC selfrenewal and controlling the expression of
differentiation genes. The phenotype associated with HP1c
depletion is an intermediate between those described for the two
other proteins by two aspects. First, the supression of HP1c slows
down the cell cycle without decreasing the expression of
Figure 5. HP1c knockdown improves early differentiation of
ESC. The transcriptome of shN2 cells was compared to that of shCTR
cells using Affymetrix chip hybridization. RNA were isolated from cells
that were cultivated in the absence of LIF and in non-adherent
conditions to form embryoid bodies (EB) over the course of 36 hours. A.
RNA levels of the three pluripotent transcription factors measured by
real time PCR in the same RNA extracts that were compared by
microarrays analysis. B. Variation of genes associated with differentia-
tion are represented relative to the mean value obtained in
undifferentiated shCTR RNA. Upregulated expression is indicated in
red, downregulated expression is indicated in green; the variations
obtained from the three independent differentiation experiments are
represented.
doi:10.1371/journal.pone.0015507.g005
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second, the depletion of HP1c orientates the differentiation as
described for Chd1 [12]. Both Tip60/p400 and Chd1 recognize
methylated H3K4 that are associated with active genes [47] and
are abundantly represented in ESC chromatin [20] [21].
Differently from the two other chromatin binding proteins,
HP1c recognizes histone marks associated with heterochromatin
formation and gene silencing. The results presented here suggest
that pathways regulating the function of apparently antagonistic
epigenetic regulators converge to maintain ESC identity, notably
in their ability to give rise to a well-balanced pattern of
differentiation between the three germ lineages. Understanding
how HP1c is regulated to sustain specific functions will provide
insight into the underlying network.
Figure 6. HP1c deprivation of ESC specifies differentiation during embryoid bodies formation. The three shRNA cell lines (shN1, shN2
and shCTR) were induced to differentiate by embryoid bodies formation. Differentiation efficiency was assessed following the decrease of
pluripotency markers (purple). Transcript levels of markers representing the three germ layers (neuroectoderm in blue, mesoderm in red and
endoderm in green) were measured by RT-qPCR each day (d) after seeding. Results represented relatively to the value obtained in ESC (d0), are the
mean of duplicates +/2 SD from one experiment representative of two.
doi:10.1371/journal.pone.0015507.g006
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Plasmids and production of lentiviral vectors
The short hairpin (sh) lentiviral vectors used were Mission-
shRNA (derived from pLKO.1-puro) purchased from Sigma
(MISSIONH shRNA; Sigma-Aldrich, St. Louis). Self-inactivating
HIV-1-derived vectors were generated by the transient transfection
of 293T cells as previously described [48] using pCMV-G [49] and
pCMVdeR8.91 [50]. Viral supernatants were harvested 24 hours
after transfection and then filtered on 0.45 mm porosity filter.
ES cell culture, retroviral infection and differentiation
CGR8 mouse ESC were grown on gelatin coated dishes in
proliferation medium (Glasgow’s modified Eagle’s medium
supplemented with 10% fetal calf serum (FCV) (PerbioScience,
Berbieres, France), 10% of non essential amino acids (Invitrogen
Carlsbad, CA), 10% of sodium pyruvate (Invitrogen) and 1000 U/
ml LIF (Abcys, Paris, France).
For lentiviral infection, CGR8 cells were plated at a density of
2.10
5 cells per 4 cm dish and cultivated for 24 hours. The viral
supernatant was then added and ESC were cultivated for 24 hours
before selection by puromycin (1 mg/ml) (Invitrogen) for 4 days.
Resistant colonies were dissociated and pooled for amplification in
the presence of puromycin for 2 days before all analysis.
For retinoic acid (RA)-induced differentiation, 5.10
5 cells were
seeded per 4 cm dish. RA (Sigma Aldrich) was added at a final
concentration of 10
27 M 24 hours after plating (referred to as day
0) in ES cells differentiation medium that is the same as
proliferation medium but without LIF and with 5% FCV.
For EB-induced differentiation, proliferating cells were seeded
in differentiation medium (final density 6.10
5 cells in 10 ml) and
allowed to float in non-adherent Petri dishes during the indicated
times.
Decreasing LIF concentration assay
Cells in exponential phase of growth were seeded at very low
density (10
4 cells in a 3.5 cm diameter dish) and cultured for 5 days
before alkaline phosphatase staining and analysis.
Detection of alkaline phosphatase activity
Cells were fixed for 30 min at 4uC (1.5% formaldehyde and
0.5% glutaraldehyde in PBS). After washes with PBS, the cells
Figure 7. Specification of ESC differentiation by HP1c deprivation is also observed in retinoic acid-induced cells. The three shRNA cell
lines (shN1, shN2 and shCTR) were induced to differentiate using retinoic acid. Differentiation efficiency was assessed following the decrease of
pluripotency markers (in purple). Transcript levels of markers representing the three germ layers (neuroectoderm in blue, mesoderm in red and
endoderm in green) were measured by RT-qPCR after 2 or 6 days of differentiation. Results represented relatively to the value obtained in ESC (d0),
are the mean of duplicates +/2 SD from one experiment representative of three.
doi:10.1371/journal.pone.0015507.g007
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prepared according to the manufacturers’ instructions. Colonies
were observed and counted using an inverted microscope (Axovert
135, Zeiss).
Measurment of cell proliferation by BrdU incorporation
assay
ES cells were seeded in 96-well dishes at a density of 2610
3
cells/well and cultivated overnight to obtain 40% confluence.
BrdU from the ELISA BrdU kit (Roche Applied Science, Basel,
Switzerland) was added to the wells for the last 8 hours of culture.
BrdU incorporation was measured by colorimetry according to the
manufacturer’s instructions.
Cell cycle analysis
Exponentially growing ESC were refed with fresh medium and
incubatedfor2 hours.BrdU wasthen added at a finalconcentration
of 50 mM and the cells were incubated for 40 minutes. The cells
were trypsinised and 5 million of them were fixed and labeled with
propidium iodide and anti-BrdU antibody as described [51]. Flow
cytometryanalyseswereperformedusingFACS(FACScalibur4C+
HTS; BD Biosciences). Data acquisition was performed using the
CellQuest Pro software (BD Bioscience).
Cell death detection
The cells were cultivated overnight. The supernatant was
removed and the cells were dissociated using trypsine/EDTA
(Invitrogen). After centrifugation and washing with PBS, Annexin
V labeling (Bender Med Systems) was performed according to the
manufacturer’s instructions. Just before analysis by flow cytometry
BrdU was added at a final concentration of 1 mg.mL
21.
Detection of Stem Cell-Specific Embryonic Antigen-1
expression
Dissociated cells were labeled using PE-labeled anti-SSEA1
antibody (anti-SSEA1-phycoerythrin, R&D Systems Inc., Min-
neapolis) applied for 45 min on ice. After washing, the fluorescence
intensity was determined by flow cytometry.
Measurment of the Brachyury promoter activity
The cells were infected with a lentivirus containing a GFP
transgene under the control of the Brachyury gene promoter
(Brachyury-eGFP, Addgene). After one week of culture, the cell
line was transduced with short hairpin vectors directed against
HP1c (N1 and N2) or control. Transduced cells were selected by
culture in the presence of puromycin for a week before analysis by
flow cytometry.
Real Time Quantitative Polymerase Chain Reaction
(RT -QPCR)
RNA was extracted using an RNeasy kit with on-column DNase
digestion, according to the manufacturer’s recommendations
(Qiagen, Hilden, Germany). Reverse transcription was carried
out with 1 mg of RNA and SuperScript II (Invitrogen) according to
the manufacturers’ recommendations.
Real-Time PCR was performed using the MXP-300P PCR-
system (Stratagene, Amsterdam, Netherlands) and Mix-Quantitect
SYBR Green (Qiagen, Hilden, Germany) as reagent. Regimens of
40 cycles at 95uC for 30 seconds, at 55uC for 1 minute and 72uC
for 30 seconds were applied. Samples were run in duplicate and
gene expression levels were calculated using Delta Delta Ct
(http://www.gene-quantification.info/) normalized with the
mouse 40S ribosomal protein S17 as housekeeping gene. The
number of independent experiments performed is indicated in
each figure legend.
Oligonucleotide sequences
The oligonucleotide primers for PCR, listed in Table 2, were
designed using the Primer3 software (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_results.cgi) and were purchased from
MWG (Eurofins MWG Operon, Ebersberg, Germany). Qiagen
Quantitec primers (Qiagen) were used for the RT-qPCR
validation of cell growth-associated gene (Table S1).
Western blots
Cytoplasmic proteins separated on 10% SDS-polyacrylamide
gels were transfered on Hybond ECL membranes (GE Health-
care). Blots were submitted to Western analysis using the following
antibodies: anti-HP1c (clone 2MOD-1G6AS, Euromedex), anti-
Oct-3/4 (clone H-134, Santa Cruz Biotechnology), anti-Nanog
(ab-21603, Abcam), anti-b tubulin (clone TUB2.1, Sigma).
Affymetrix GeneChip Assays
Experimental design. Three completely independent
experiments were carried out, with three independent infections,
cell cultures and EB experiments.
Processing of RNA. Biotinylated antisense cRNA for
microarray hybridization was prepared using the GeneChipH
One-Cycle target labeling kit and procedures from Affymetrix
(Santa Clara, CA, USA). cRNA quantification was performed with
Figure 8. HP1c protein level remains constant during ESC
differentiation. ESC cells were induced to differentiate using 100 nM
retinoic acid for 1 to 8 days (upper figure) or by embryoid bodies
formation for 1 to 5 days (lower figure). The expression of the HP1c,
Oct4 and Nanog proteins were observed by western blot. Beta-tubulin
was used as a protein loading control.
doi:10.1371/journal.pone.0015507.g008
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(Agilent technologies, Inc, Palto Alto, CA, USA).
Array hybridization and scanning. Microarray analyses
were performed using high-density oligonucleotide arrays (Mouse
Genome 430 2.0 Array, Affymetrix). Biotinylated cRNA (15 mg)
was fragmented and hybridization on the chip was performed
following the Affymetrix protocol (http://www.affymetrix.com).
Washing and staining were performed in a Fluidics Station 450
(Affymetrix). The arrays were scanned with a confocal laser
(Genechip Scanner 3000, Affymetrix) and analysed with
Expression Console Software (Affymetrix).
Microarray data analysis. The results were filtered using
Genespring 7.3.1 (Agilent). A first selection of genes was
performed by pairwise comparisons between shCTR and shN2
(table 1) or between shCTR, shN2, shCTR-EB36h and shN2-
EB36h (Figure 5). Each sample from one group was compared
with each sample from the other group, and only genes showing a
fold change $1.8 between groups were retained. A gene was
considered differentially expressed only if it met the above criteria
in all pairwise comparisons and if the detected signal was above
the background in at least one of the compared groups, thereby
carrying a statistically significant absolute call of ‘present’ or
‘marginal’ in all samples.
A list of genes associated with differentiation was generated with
MedscanReader 2.2 (Ariadne Genomics) and Pathway Studio 6.2
(Ariadne Genomics) software that enables the automated extraction
of information from scientific text (list displayed as supplementary
data). Genes that were differentially expressed or common to the
generated list were clustered into a tree based on Pearson
correlation with the average linkage used as a clustering algorithm.
Microarray validation by RT-qPCR. To validate the
results of the microarray analysis, seven genes of biological
significance were subjected to RT-qPCR and their expression
levels were measured (Table S2).
All microarray data is MIAME compliant and the raw data has
been deposited in Array Express at http://www.ebi.ac.uk/
microarray-as/ae/. Accession number is E-MEXP-2238.
Supporting Information
Table S1 Validation of microarray fold change by RT-qPCR
for genes associated with cell growth. (RTF)
Table S2 Microarrays validation by RT-qPCR. (RTF)
File S1 List of the genes displayed in Figure 5B. (RTF)
Acknowledgments
We thank Dr F. Lavial, Dr I. Aksoy for qPCR primers sequences; Dr D.
Ne `gre and V. Barateau from the IFR128 Vectorology platform for the
production of the lentivirus; Dr L. Genestier for his help with cell death
analysis; Severine Croze for microarray experiments; Dr A. Wierinckx and
Pr J. Lachuer from the Genomic platform Profilexpert for the analysis of
microarray experiments; and Kita-Matsuo for the gift of the brachyury-
eGFP plasmid (addgene 21063); Dr Pierre Savatier and Dr Pierre-Yves
Bourillot for helpfull suggestions on this work.
Author Contributions
Conceived and designed the experiments: MC ST AM. Performed the
experiments: MC ST VT. Analyzed the data: MC JS AM. Contributed
reagents/materials/analysis tools: MC ST VT AMB. Wrote the paper:
MC AM.
Table 2. Oligonucleotide primers used in QPCR experiments.
Gene Sense Antisense
Brachyury CCGGTGCTGAAGGTAAATGT CCTCCATTGAGCTTGTTGGT
Cbx1 GTCAAGGGCAAGGTGGAATA CCTCGTGGCTTTTCTGACTC
Cbx3 GAGATGCTGCTGACAAACCA GCTCCTCGTAGAAGGCAATG
Cbx5 TCTGTCATTGCCACTTGAGC CCCTTCCTTCACCACTGTGT
Cxcr4 TCCTGCCCACCATCTACTTG CTTTTCAGCCAGCAGTTTCC
Eomes GGCAAAGCGGACAATAACAT AGCCTCGGTTGGTATTTGTG
Fgf5 CGCTTTGACTGGAACTAAAC GAATGCTAACCATCCTCAAA
Flk1 GTAAAAGCAGGGAGTCTGTG GTGGTGGAAAGAACAACACT
Foxa2 TGGTCACTGGGGACAAGGGAA CTGCAACAACAGCAATAGAGAACAAC
Gata4 CTGTGCCAACTGCCAGACTA GCATCTCTTCACTGCTGCTG
Gata6 ACAGCCCACTTCTGTGTTC TGGGTTGGTCACGTGGTACA
Hnf1 GATGTCAGGAGTGCGCTACA CTGAGATTGCTGGGGATTGT
Mixl1 GCACGTCGTTCAGCTCGGAG GTCATGCTGGGATCCGGAACGTG
Musashi1 CGGGGAACTGGTAGGTGTAA ATGCTGGGTATTGGGATGCT
Nanog AAGTACCTCAGCCTCCAGCA GTGCTGAGCCCTTCTGAATC
Nestin GAAGACCAGCAGGCGTTTAG TCCTCTGCGTCTTCAAACCT
Oct4 CACGAGTGGAAAGCAACTCA AGATGGTGGTCTGGCTGAAC
Pdgfr a CAAGAGAGTGACTGGCCACA CGGTTCCAGTACCTTCCAAA
Rex1 CGTGTAACATACACCATCCG GAAATCCTCTTCCAGAATGG
Rs17 ATGACTTCCACACCAACAAGC GCCAACTGTAGGCTGAGTGAC
Sox1 CACAACTCGGAGATCAGCAA GTCCTTCTTGAGCAGCGTCT
Tbx2 CGAGGAGTCAGTCTATCCAG ACCTCTACCCTATGCACCTT
doi:10.1371/journal.pone.0015507.t002
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